Manufacturing company Nordson (NASDAQ: NDSN) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 8.5% year on year to $740.8 million. Guidance for next quarter’s revenue was better than expected at $775 million at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $2.86 per share was in line with analysts’ consensus estimates.

Is now the time to buy NDSN? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Nordson’s first quarter performance was well received by the market, driven by broad-based revenue growth across all segments and sustained margin expansion. Management attributed the results to solid execution in key end markets such as electronics, medical, and industrial applications, with a notable increase in order entry and backlog supporting these gains. CEO Sundaram Nagarajan highlighted the company’s ability to leverage its differentiated technology and close-to-customer approach, stating, “All 3 segments contributed to our organic growth performance, surpassing the midpoint expectations of last quarter’s sales and earnings guidance.”

Looking ahead, management’s raised guidance reflects confidence in persistent demand momentum, particularly in electronics and semiconductor end markets. The company is betting on its diversified product portfolio and recent acquisition of CapstanAG to fuel additional growth. CFO Daniel Hopgood pointed to robust backlog and broad-based order entry as key factors, while also cautioning that the outlook balances recent strength with prudent consideration of macroeconomic uncertainties. Nagarajan emphasized, “If we sustain the current demand trends, particularly in electronics end markets, we believe we are well positioned to deliver the upper end of our guidance.”

Key Insights from Management’s Remarks

Management credited the quarter’s performance to strong execution in high-growth technology markets, effective capital deployment, and the successful integration of a strategic acquisition.

• Electronics and semiconductor strength: The Advanced Technology Solutions segment saw robust growth, particularly in electronics dispense and test and inspection systems, benefiting from rising demand for semiconductor manufacturing and AI infrastructure applications. Management cited early-stage momentum in panel-level packaging and optical fiber content as key drivers.

• Medical recovery ongoing: The Medical and Fluid Solutions segment is returning to normalized growth rates, with management noting steady improvement in medical product lines and backlog. While near-term margin headwinds arose from regulatory-driven product changes, management expects these to become opportunities as the year progresses. However, management clarified that the mix within the segment is still a bit different than long-term expectations, and normalization is ongoing rather than fully complete.

• Industrial and packaging resilience: The Industrial Precision Solutions unit delivered improved demand across industrial coating, polymer processing, and packaging applications, with a notable uptick in both system and consumable orders reflecting customer confidence in broader end-market recovery.

• Precision agriculture expansion: The acquisition of CapstanAG, a precision agriculture company with pulse width modulation technology, expands Nordson’s North American footprint and product offering for mid-tier original equipment manufacturers. This move builds on the earlier ARAG acquisition, consolidating facilities and aligning with growth objectives for the Precision Ag division.

• Operational leverage and cash deployment: Margin expansion was supported by disciplined SG&A (selling, general, and administrative expense) management and effective free cash flow conversion. Management highlighted a continued focus on strategic capital deployment through share repurchases, dividends, and targeted M&A, while maintaining conservative leverage.

Drivers of Future Performance

Management’s outlook centers on sustained demand in electronics and medical markets, supported by order momentum, recent M&A, and ongoing operational discipline.

• Semiconductor and electronics demand: Nordson expects continued growth in its Advanced Technology Solutions segment, underpinned by expanding semiconductor applications such as AI, panel-level packaging, and increased optical fiber content. Management believes the current cycle is in its early stages, with demand for both dispense and test and inspection products supporting backlog and revenue visibility.

• Medical segment normalization: The company anticipates ongoing recovery in its medical business, aiming for a return to normalized 6–8% growth rates. Management noted that recent regulatory-driven material changes in certain product lines are temporary and should transition from headwinds to margin opportunities as operational adjustments take effect.

• Inflationary environment and pricing discipline: While broader inflationary pressures and tariffs impact input costs, Nordson is managing these headwinds through selective pricing actions and operational efficiencies. Management is focused on maintaining margins in this environment rather than expanding them, highlighting the importance of cost control and efficiency gains across all segments.

Catalysts in Upcoming Quarters

In future quarters, the StockStory team will be monitoring (1) sustained order entry and backlog trends across electronics and medical segments, (2) the integration and commercial impact of the CapstanAG acquisition in precision agriculture, and (3) the company’s ability to offset inflationary and tariff headwinds through pricing and operational efficiencies. Execution on new product introductions and continued cash flow strength will also be key signposts for assessing ongoing momentum.

Nordson currently trades at $285.80, up from $276.20 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.